An in vivo role for Trypanosoma cruzi calreticulin in antiangiogenesis

Molecular and Biochemical Parasitology

Volumn 140, Issue 2, 2005, Pages 133-140

  Molina, María C ^a   Ferreira, Viviana ^a   Valck, Carolina ^a   Aguilar, Lorena ^a   Orellana, Juana ^a   Rojas, Alvaro ^a   Ramirez, Galia ^a   Billetta, Rosario ^b   Schwaeble, Wilhelm ^c   Lemus, David ^a   Ferreira, Arturo ^a  

^a UNIVERSITY OF CHILE   (Chile)

^b Androclus Therapeutics   (United States)

^c UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Antiangiogenesis; Calreticulin; Trypanosoma cruzi

Indexed keywords

ANTINEOPLASTIC AGENT; CALRETICULIN; PROTOZOAL PROTEIN; RECOMBINANT PROTEIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; BACTERIAL INFECTION; BIOASSAY; CHICK EMBRYO; CHORIOALLANTOID MEMBRANE ASSAY; CONTROLLED STUDY; DRUG POTENCY; DRUG SCREENING; EPIMASTIGOTE; GENE CONSTRUCT; GENE VECTOR; GENETIC CODE; GENETIC TRANSDUCTION; MOUSE; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTOZOAL GENETICS; PROTOZOON; SEQUENCE HOMOLOGY; TRYPANOSOMA CRUZI; TUMOR VASCULARIZATION;

EID: 20044363605     PISSN: 01666851     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molbiopara.2004.12.014     Document Type: Article

References (43)

1. J. Folkman Angiogenesis in cancer, vascular, rheumatoid and other disease Nat Med 1 1995 27 31
2. W. Risau Mechanisms of angiogenesis Nature 386 1997 671 674
3. P. Carmeliet, and R.K. Jain Angiogenesis in cancer and other diseases Nature 407 2000 249 257
4. R.K. Jain Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy Nat Med 7 2001 987 989
5. W.H. Burgess, and T. Maciag The heparin-binding (fibroblast) growth factor family of proteins Annu Rev Biochem 58 1989 575 606
6. M.S. Pepper, D. Belin, R. Montesano, L. Orci, and J.D. Vassalli Transforming growth factor-beta 1 modulates basic fibroblast growth factor-induced proteolytic and angiogenic properties of endothelial cells in vitro J Cell Biol 111 1990 743 755
7. G.A. Meininger, and M.J. Davis Cellular mechanisms involved in the vascular myogenic response Am J Physiol 263 1992 H647 H659
8. J.C. Aguillon, C. Bustos, and P. Vallejos Purification and preliminary sequencing of Tc-45, an immunodominant Trypanosoma cruzi antigen: absence of homology with cruzipain, cruzain, and a 46-kiloDalton protein Am J Trop Med Hyg 53 1995 211 215
9. J.C. Aguillon, R. Harris, and M.C. Molina Recognition of an immunogenetically selected Trypanosoma cruzi antigen by seropositive chagasic human sera Acta Trop 63 1997 159 166
10. J.C. Aguillon, L. Ferreira, and C. Perez Tc45, a dimorphic Trypanosoma cruzi immunogen with variable chromosomal localization, is calreticulin Am J Trop Med Hyg 63 2000 306 312
11. K. Marcelain, A. Colombo, and M.C. Molina Development of an immunoenzymatic assay for the detection of human antibodies against Trypanosoma cruzi calreticulin, an immunodominant antigen Acta Trop 75 2000 291 300
12. J.C. Aguillon, T. Hermosilla, and M.C. Molina Trypanosoma cruzi: H2 complex and genetic background influence on the humoral immune response against epimastigotes Int J Parasitol 30 2000 981 984
13. V. Ferreira, M.C. Molina, C. Valck, A. Rojas, and A. Ferreira Parasite calreticulin: possible roles in the parasite/host interface Inmunología 21 2002 156 168
14. V. Ferreira, M.C. Molina, and C. Valck Role of calreticulin from parasites in its interaction with vertebrate hosts Mol Immunol 40 2004 1279 1291
15. V. Ferreira, C. Valck, and G. Sanchez The classical activation pathway of the human complement system is specifically inhibited by calreticulin from Trypanosoma cruzi J Immunol 172 2004 3042 3050
16. L. Yao, S.E. Pike, and G. Tosato Laminin binding to the calreticulin fragment vasostatin regulates endothelial cell function J Leukoc Biol 71 2002 47 53
17. S.E. Pike, L. Yao, and K.D. Jones Vasostatin, a calreticulin fragment, inhibits angiogenesis and suppresses tumor growth J Exp Med 188 1998 2349 2356
18. S.E. Pike, L. Yao, and J. Setsuda Calreticulin and calreticulin fragments are endothelial cell inhibitors that suppress tumor growth Blood 94 1999 2461 2468
19. W.F. Cheng, C.F. Hung, and C.Y. Chai Tumor-specific immunity and antiangiogenesis generated by a DNA vaccine encoding calreticulin linked to a tumor antigen J Clin Invest 108 2001 669 678
20. J. Folkman, and D.E. Ingber Angiostatic steroids. Method of discovery and mechanism of action Ann Surg 206 1987 374 383
21. L.K. Mostafa, D.B. Jones, and D.H. Wright Mechanism of the induction of angiogenesis by human neoplastic lymphoid tissue: studies on the chorioallantoic membrane (CAM) of the chick embryo J Pathol 132 1980 191 205
22. G.J. Petruzzelli, C.H. Snyderman, J.T. Johnson, and E.N. Myers Angiogenesis induced by head and neck squamous cell carcinoma xenografts in the chick embryo chorioallantoic membrane model Ann Otol Rhinol Laryngol 102 1993 215 221
23. F. Buttgereit, M. Wehling, and G.R. Burmester A new hypothesis of modular glucocorticoid actions: steroid treatment of rheumatic diseases revisited Arthritis Rheum 41 1998 761 767
24. J.P. Quigley, and P.B. Armstrong Tumor cell intravasation alu-cidated: the chick embryo opens the window Cell 94 1998 281 284
25. D. Ribatti, M.T. Conconi, and B. Nico Angiogenic response induced by acellular brain scaffolds grafted onto the chick embryo chorioallantoic membrane Brain Res 989 2003 9 15
26. D. Lemus, A. Dabancens, and J. Illanes Antiangiogenic effect of betamethasone on the chick cam stimulated by TA3 tumor supernatant Biol Res 34 2001 227 236
27. J. Zuniga, M. Fuenzalida, and A. Guerrero Effects of steroidal and non-steroidal drugs on the neovascularization response induced by tumoral TA3 supernatant on CAM from chick embryo Biol Res 36 2003 233 240
28. G.I. Roskin Toxin therapy of experimental cancer Cancer Res 6 1946 363 365
29. T.S. Hauschka, and M.B. Goodwin Trypanosoma cruzi endotoxin (KR) in the treatment of malignant mouse tumors Science 107 1948 600 602
30. H.R. Cabral The tumoricidal effect of Trypanosoma cruzi: its intracellular cycle and the immune response of the host Med Hypotheses 54 2000 1 6
31. E.C. Oliveira, M.S. Leite, and J.A. Miranda Chronic Trypanosoma cruzi infection associated with low incidence of 1,2-dimethylhydrazine-induced colon cancer in rats Carcinogenesis 22 2001 737 740
32. J. Sambrook, E.F. Fritsch, and T. Maniatis Molecular Cloning: a Laboratory Manual 2 ed. 1989 Cold Spring Harbor Laboratory Press Cold Spring Harbor
33. Y. Aida, and M.J. Pabst Removal of endotoxin from protein solutions by phase separation using Triton X-114 J Immunol Methods 132 1990 191 195
34. F. Xiao, Y. Wei, and L. Yang A gene therapy for cancer based on the angiogenesis inhibitor, vasostatin Gene Ther 9 2002 1207 1213
35. A. Bikfalvi, and Z.C. Han Angiogenic factors are hematopoietic growth factors and vice versa Leukemia 8 1994 523 529
36. D. Valdembri, G. Serini, A. Vacca, D. Ribatti, and F. Bussolino In vivo activation of JAK2/STAT-3 pathway during angiogenesis induced by GM-CSF Faseb J 16 2002 225 227
37. E. Engvall, and P. Perlman Enzyme-linked immunosorbent assay (ELISA). Quantitative assay of immunoglobulin G Immunochemistry 8 1971 871 874
38. E. Pipili-Synetos, S. Kritikou, and E. Papadimitriou Nitric oxide synthase expression, enzyme activity and NO production during angiogenesis in the chick chorioallantoic membrane Br J Pharmacol 129 2000 207 213
39. F.A. Arosa, O. de Jesus, G. Porto, A.M. Carmo, and M. de Sousa Calreticulin is expressed on the cell surface of activated human peripheral blood T lymphocytes in association with major histocompatibility complex class I molecules J Biol Chem 274 1999 16917 16922
40. I. Ghiran, L.B. Klickstein, and A. Nicholson-Weller Calreticulin is at the surface of circulating neutrophils and uses CD59 as an adaptor molecule J Biol Chem 278 2003 21024 21031
41. B.R. Zetter Angiogenesis and tumor metastasis Annu Rev Med 49 1998 407 424
42. L. Yao, S.E. Pike, and S. Pittaluga Anti-tumor activities of the angiogenesis inhibitors interferon-inducible protein-10 and the calreticulin fragment vasostatin Cancer Immunol Immunother 51 2002 358 366
43. L. Yao, S.E. Pike, and J. Setsuda Effective targeting of tumor vasculature by the angiogenesis inhibitors vasostatin and interleukin-12 Blood 96 2000 1900 1905